104 related articles for article (PubMed ID: 9207940)
1. Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study.
Spadoni G; Balsamini C; Diamantini G; Di Giacomo B; Tarzia G; Mor M; Plazzi PV; Rivara S; Lucini V; Nonno R; Pannacci M; Fraschini F; Stankov BM
J Med Chem; 1997 Jun; 40(13):1990-2002. PubMed ID: 9207940
[TBL] [Abstract][Full Text] [Related]
2. 1-(2-Alkanamidoethyl)-6-methoxyindole derivatives: a new class of potent indole melatonin analogues.
Tarzia G; Diamantini G; Di Giacomo B; Spadoni G; Esposti D; Nonno R; Lucini V; Pannacci M; Fraschini F; Stankov BM
J Med Chem; 1997 Jun; 40(13):2003-10. PubMed ID: 9207941
[TBL] [Abstract][Full Text] [Related]
3. Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study.
Mor M; Rivara S; Silva C; Bordi F; Plazzi PV; Spadoni G; Diamantini G; Balsamini C; Tarzia G; Fraschini F; Lucini V; Nonno R; Stankov BM
J Med Chem; 1998 Sep; 41(20):3831-44. PubMed ID: 9748358
[TBL] [Abstract][Full Text] [Related]
4. 2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists.
Spadoni G; Balsamini C; Bedini A; Diamantini G; Di Giacomo B; Tontini A; Tarzia G; Mor M; Plazzi PV; Rivara S; Nonno R; Pannacci M; Lucini V; Fraschini F; Stankov BM
J Med Chem; 1998 Sep; 41(19):3624-34. PubMed ID: 9733487
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of the human melatonin Mel1a receptor following stable transfection into NIH3T3 cells.
Nonno R; Lucini V; Pannacci M; Mazzucchelli C; Angeloni D; Fraschini F; Stankov BM
Br J Pharmacol; 1998 Jun; 124(3):485-92. PubMed ID: 9647472
[TBL] [Abstract][Full Text] [Related]
6. Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles.
Davies DJ; Garratt PJ; Tocher DA; Vonhoff S; Davies J; Teh MT; Sugden D
J Med Chem; 1998 Feb; 41(4):451-67. PubMed ID: 9484496
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional quantitative structure-activity relationship of melatonin receptor ligands: a comparative molecular field analysis study.
Sicsic S; Serraz I; Andrieux J; Brémont B; Mathé-Allainmat M; Poncet A; Shen S; Langlois M
J Med Chem; 1997 Feb; 40(5):739-48. PubMed ID: 9057860
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of potent N1-substituted indole melatonin receptor agonists.
Tsotinis A; Eleutheriades A; Hough K; Sugden D
Chem Commun (Camb); 2003 Feb; (3):382-3. PubMed ID: 12613623
[TBL] [Abstract][Full Text] [Related]
9. Bicyclic melatonin receptor agonists containing a ring-junction nitrogen: Synthesis, biological evaluation, and molecular modeling of the putative bioactive conformation.
Elsner J; Boeckler F; Davidson K; Sugden D; Gmeiner P
Bioorg Med Chem; 2006 Mar; 14(6):1949-58. PubMed ID: 16290939
[TBL] [Abstract][Full Text] [Related]
10. Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors.
Marot C; Chavatte P; Morin-Allory L; Viaud MC; Guillaumet G; Renard P; Lesieur D; Michel A
J Med Chem; 1998 Nov; 41(23):4453-65. PubMed ID: 9804685
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of new melatonin dimeric derivatives.
Di Giacomo B; Bedini A; Spadoni G; Tarzia G; Fraschini F; Pannacci M; Lucini V
Bioorg Med Chem; 2007 Jul; 15(13):4643-50. PubMed ID: 17481904
[TBL] [Abstract][Full Text] [Related]
12. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
Lucini V; Pannacci M; Scaglione F; Fraschini F; Rivara S; Mor M; Bordi F; Plazzi PV; Spadoni G; Bedini A; Piersanti G; Diamantini G; Tarzia G
J Med Chem; 2004 Aug; 47(17):4202-12. PubMed ID: 15293992
[TBL] [Abstract][Full Text] [Related]
13. Reassessing the melatonin pharmacophore--enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue.
Rivara S; Diamantini G; Di Giacomo B; Lamba D; Gatti G; Lucini V; Pannacci M; Mor M; Spadoni G; Tarzia G
Bioorg Med Chem; 2006 May; 14(10):3383-91. PubMed ID: 16431121
[TBL] [Abstract][Full Text] [Related]
14. Guanosine 5'-O-(3-thiotriphosphate) and cations regulate melatonin receptors, and melatonin inhibits cyclic AMP production in the spinal cord.
Wan Q; Liao MX; Pang CS; Pang SF; Brown GM
Biol Signals; 1997; 6(2):67-76. PubMed ID: 9266094
[TBL] [Abstract][Full Text] [Related]
15. mt(1) Receptor-mediated antiproliferative effects of melatonin on the rat uterine antimesometrial stromal cells.
Zhao H; Pang SF; Poon AM
Mol Reprod Dev; 2002 Feb; 61(2):192-9. PubMed ID: 11803554
[TBL] [Abstract][Full Text] [Related]
16. Studies on the vasoconstrictor action of melatonin and putative melatonin receptor ligands in the tail artery of juvenile Wistar rats.
Ting KN; Dunn WR; Davies DJ; Sugden D; Delagrange P; Guardiola-Lemaître B; Scalbert E; Wilson VG
Br J Pharmacol; 1997 Dec; 122(7):1299-306. PubMed ID: 9421275
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP
Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848
[TBL] [Abstract][Full Text] [Related]
18. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
[TBL] [Abstract][Full Text] [Related]
20. Methods for the evaluation of drug action at the human melatonin receptor subtypes.
Nonno R; Fraschini F; Stankov BM
Biol Signals Recept; 1999; 8(1-2):32-40. PubMed ID: 10085460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
